{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:19:08Z","timestamp":1790360348537,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 841 A5"],"award-info":[{"award-number":["SFB 841 A5"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU-hepatitis 05.815"],"award-info":[{"award-number":["TTU-hepatitis 05.815"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000019"],"award-info":[{"award-number":["MOH-000019"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-StaR17Nov-0001"],"award-info":[{"award-number":["MOH-StaR17Nov-0001"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.xcrm.2020.100060","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T10:32:06Z","timestamp":1595327526000},"page":"100060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes"],"prefix":"10.1016","volume":"1","author":[{"given":"Christine Y.L.","family":"Tham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Kah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassilo","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Giersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Ladiges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Loglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Sureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Lampertico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"L\u00fctgehetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Dandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bertoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1, Suppl","key":"10.1016\/j.xcrm.2020.100060_bib1","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.jhep.2016.02.013","article-title":"The hepatitis delta virus: replication and pathogenesis","volume":"64","author":"Sureau","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2020.100060_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jhep.2010.02.001","article-title":"Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDV","volume":"52","author":"Wedemeyer","year":"2010","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0037-1621711","article-title":"Targeting Hepatitis D","volume":"38","author":"Rizzetto","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.xcrm.2020.100060_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2018.09.058","article-title":"Pathogenesis of and New Therapies for Hepatitis D","volume":"156","author":"Koh","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2020.100060_bib6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2468-1253(17)30288-1","article-title":"Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial","volume":"2","author":"Bazinet","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hep.29658","article-title":"Optimizing lonafarnib treatment for the management of chronic delta hepatitis: the LOWR HDV-1 study","volume":"67","author":"Yurdaydin","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2020.100060_bib8","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S0618-8278(19)30141-0","article-title":"GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV\/HDV co-infection","volume":"70","author":"Wedemeyer","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2020.100060_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.gastro.2018.10.032","article-title":"Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection","volume":"156","author":"Gehring","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2020.100060_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T\u00a0cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100060_bib12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2020.100060_bib13","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.510250631","article-title":"Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer","volume":"25","author":"Lau","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2020.100060_bib14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep.1840180204","article-title":"Adoptive transfer of immunity to hepatitis B virus after T\u00a0cell-depleted allogeneic bone marrow transplantation","volume":"18","author":"Ilan","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2020.100060_bib15","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2020.100060_bib16","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2020.100060_bib17","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100060_bib18","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1084\/jem.20131333","article-title":"Dysfunctional CD8+ T\u00a0cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction","volume":"211","author":"Kurktschiev","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2020.100060_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","article-title":"Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T\u00a0cells in chronically HBV-infected patients with low viral load","volume":"68","author":"Schuch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2020.100060_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.gastro.2007.11.002","article-title":"T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes","volume":"134","author":"Bohne","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2020.100060_bib21","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1172\/JCI93024","article-title":"Lymphocytes transiently expressing virus-specific T\u00a0cell receptors reduce hepatitis B virus infection","volume":"127","author":"Kah","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2020.100060_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5009\/gnl17233","article-title":"Immunotherapy for Chronic Hepatitis B Virus Infection","volume":"12","author":"Bertoletti","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.xcrm.2020.100060_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2018.03.027","article-title":"Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3","volume":"155","author":"Koh","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2020.100060_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jcyt.2018.02.002","article-title":"HBsAg-redirected T\u00a0cells exhibit antiviral activity in HBV-infected human liver chimeric mice","volume":"20","author":"Kruse","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.xcrm.2020.100060_bib25","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1172\/JCI120228","article-title":"T cell receptor grafting allows virological control of Hepatitis B virus infection","volume":"129","author":"Wisskirchen","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2020.100060_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/gutjnl-2017-314713","article-title":"Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in\u00a0vitro and in\u00a0vivo","volume":"68","author":"Giersch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2020.100060_bib27","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1053\/j.gastro.2019.02.003","article-title":"Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level","volume":"156","author":"Karimzadeh","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2020.100060_bib28","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1053\/j.gastro.2019.01.035","article-title":"Hepatitis D Virus-Specific CD8+ T Cells Have a Memory-Like Phenotype Associated With Viral Immune Escape in Patients With Chronic Hepatitis D Virus Infection","volume":"156","author":"Kefalakes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2020.100060_bib29","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1128\/JVI.00605-15","article-title":"Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In\u00a0Vitro","volume":"89","author":"Hoh","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100060_bib30","doi-asserted-by":"crossref","first-page":"e01457-18","DOI":"10.1128\/JVI.01457-18","article-title":"Spatiotemporal Differences in Presentation of CD8\u00a0T Cell Epitopes during Hepatitis B Virus Infection","volume":"93","author":"Khakpoor","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100060_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2018.02.021","article-title":"Hepatitis D virus replication is sensed by MDA5 and induces IFN-\u03b2\/\u03bb responses in hepatocytes","volume":"69","author":"Zhang","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2016.10.006","article-title":"HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes","volume":"136","author":"Alfaiate","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.xcrm.2020.100060_bib33","doi-asserted-by":"crossref","first-page":"e1004840","DOI":"10.1371\/journal.ppat.1004840","article-title":"Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide","volume":"11","author":"He","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2020.100060_bib34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jhep.2015.03.011","article-title":"Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection","volume":"63","author":"Giersch","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jhep.2017.05.010","article-title":"A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-\u03b2 induction","volume":"67","author":"Su\u00e1rez-Amar\u00e1n","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib36","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T\u00a0cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T\u00a0cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2020.100060_bib37","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/JVI.01990-10","article-title":"Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody","volume":"85","author":"Sastry","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100060_bib38","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1128\/JVI.01124-08","article-title":"Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire","volume":"82","author":"Tan","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100060_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"L\u00fctgehetmann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2020.100060_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-4939-3625-0_19","article-title":"Redirecting T Cell Specificity Using T Cell Receptor Messenger RNA Electroporation","volume":"1428","author":"Koh","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2020.100060_bib41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1034\/j.1600-0676.2001.021004254.x","article-title":"Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies","volume":"21","author":"Niro","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.xcrm.2020.100060_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(88)80457-4","article-title":"Chronic HDV (hepatitis delta virus) hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease","volume":"6","author":"Negro","year":"1988","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib43","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","article-title":"A 28-year study of the course of hepatitis \u0394 infection: a risk factor for cirrhosis and hepatocellular carcinoma","volume":"136","author":"Romeo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2020.100060_bib44","doi-asserted-by":"crossref","first-page":"e20191663","DOI":"10.1084\/jem.20191663","article-title":"Challenges of CAR- and TCR-T cell-based therapy for chronic infections","volume":"217","author":"Bertoletti","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2020.100060_bib45","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2014.10.001","article-title":"Immunotherapy of HCC metastases with autologous T\u00a0cell receptor redirected T\u00a0cells, targeting HBsAg in a liver transplant patient","volume":"62","author":"Qasim","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2013.11.010","article-title":"Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection","volume":"60","author":"Giersch","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2020.100060_bib47","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/JVI.02415-06","article-title":"The level of viral antigen presented by hepatocytes influences CD8 T-cell function","volume":"81","author":"Gehring","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2020.100060_bib48","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.xcrm.2020.100060_bib49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jviromet.2011.11.001","article-title":"Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard","volume":"179","author":"Ferns","year":"2012","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.xcrm.2020.100060_bib50","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1038\/mtna.2013.43","article-title":"A practical approach to immunotherapy of hepatocellular carcinoma using T\u00a0cells redirected against hepatitis B virus","volume":"2","author":"Koh","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2020.100060_bib51","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1038\/srep04166","article-title":"Building and optimizing a virus-specific T\u00a0cell receptor library for targeted immunotherapy in viral infections","volume":"4","author":"Banu","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2020.100060_bib52","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1128\/JCM.00940-14","article-title":"Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification","volume":"52","author":"Homs","year":"2014","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.xcrm.2020.100060_bib53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","article-title":"Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in\u00a0vivo","volume":"67","author":"Allweiss","year":"2018","journal-title":"Gut"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379120300768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379120300768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:13:01Z","timestamp":1778919181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379120300768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2666379120300768"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2020.100060","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2020.100060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100060"}}